PRA9 COSTS AND BENEFITS ASSOCIATED WITH ADDITION OF SALMETEROL VERSUS MONTELUKAST TO INHALED CORTICOSTEROID THERAPY IN A MEDICAID ASTHMATIC POPULATION
May 1, 2002, 00:00
10.1016/S1098-3015(10)60983-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)60983-7/fulltext
Title :
PRA9 COSTS AND BENEFITS ASSOCIATED WITH ADDITION OF SALMETEROL VERSUS MONTELUKAST TO INHALED CORTICOSTEROID THERAPY IN A MEDICAID ASTHMATIC POPULATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)60983-7&doi=10.1016/S1098-3015(10)60983-7
First page :
Section Title :
Open access? :
No
Section Order :
171